Dominic Jauvin

Identification and Characterization of Modified Antisense Oligonucleotides Targeting DMPK in Mice and Nonhuman Primates for the Treatment of Myotonic Dystrophy Type 1

Sanjay K. Pandey, Thurman M. Wheeler, Samantha L. Justice et al. · Journal of Pharmacology and Experimental Therapeutics · 2015 · 120 citations · Full text

Pharmacy, Molecular Biology, Molecular Medicine +17

Peptide-conjugated oligonucleotides evoke long-lasting myotonic dystrophy correction in patient-derived cells and mice

Arnaud F. Klein, Miguel A. Varela, Ludovic Arandel et al. · Journal of Clinical Investigation · 2019 · 105 citations · Full text

Pharmacy, Molecular Biology, Pharmacology +17

Targeting DMPK with Antisense Oligonucleotide Improves Muscle Strength in Myotonic Dystrophy Type 1 Mice

Dominic Jauvin, Jessina Chrétien, Sanjay K. Pandey et al. · Molecular Therapy — Nucleic Acids · 2017 · 90 citations · Full text

Life Sciences, Genetics, Molecular Biology +14

Antisense oligonucleotides as a potential treatment for brain deficits observed in myotonic dystrophy type 1

Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres‐Bérard et al. · Gene Therapy · 2022 · 45 citations · Full text

Life Sciences, Neurology, Neuroscience +12

Enhanced Delivery of Ligand-Conjugated Antisense Oligonucleotides (C16-HA-ASO) Targeting Dystrophia Myotonica Protein Kinase Transcripts for the Treatment of Myotonic Dystrophy Type 1

Siham Ait Benichou, Dominic Jauvin, Thiéry De Serres‐Bérard et al. · Human Gene Therapy · 2022 · 23 citations

Medicine, Molecular Biology, Molecular Medicine +16